0001096906-22-002328.txt : 20220923
0001096906-22-002328.hdr.sgml : 20220923
20220923161402
ACCESSION NUMBER: 0001096906-22-002328
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200319
FILED AS OF DATE: 20220923
DATE AS OF CHANGE: 20220923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUEMOELLER JOHN WALTER II
CENTRAL INDEX KEY: 0001568485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54296
FILM NUMBER: 221262494
MAIL ADDRESS:
STREET 1: 305 SAN ANSELMO AVENUE
STREET 2: SUITE 300
CITY: SAN ANSELMO
STATE: CA
ZIP: 94960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC.
CENTRAL INDEX KEY: 0001514946
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274092986
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6191 CORNERSTONE COURT, E
STREET 2: SUITE 114
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (212) 751-0001
MAIL ADDRESS:
STREET 1: 6191 CORNERSTONE COURT, E
STREET 2: SUITE 114
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AXIM INTERNATIONAL INC.
DATE OF NAME CHANGE: 20110309
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-03-19
0
0001514946
AXIM BIOTECHNOLOGIES, INC.
AXIM
0001568485
HUEMOELLER JOHN WALTER II
6191 CORNERSTONE COURT, E.
SUITE 114
SAN DIEGO
CA
92121
1
1
0
0
Chief Executive Officer
Common Stock
2020-03-19
4
P
0
6000000.0000
A
6000000.0000
D
Reporting Person acquired the shares pursuant to a share exchange with the Issuer whereby Reporting Person exchanged 100% of the Sapphire Biotech, Inc. shares common stock held by Reporting Person for 6,000,000 shares of common stock of the Issuer.
/s/ John W. Huemoeller II
2022-09-23